These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19647612)

  • 41. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
    Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
    Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy.
    Kitai T; Yamanaka K; Miyauchi Y; Kawashima M
    Int J Clin Oncol; 2017 Jun; 22(3):519-525. PubMed ID: 28054141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study.
    Macrì A; Arcoraci V; Belgrano V; Caldana M; Cioppa T; Costantini B; Cucinotta E; De Cian F; De Iaco P; De Manzoni G; Di Giorgio A; Fleres F; Muffatti F; Orsenigo E; Pinna AD; Roviello F; Sammartino P; Scambia G; Saladino E
    Anticancer Res; 2014 Oct; 34(10):5689-93. PubMed ID: 25275075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Complications of cytoreductive surgery associated with intraperitoneal chemohyperthermia: prevention and treatment].
    De Simone M; Vaira M; Scuderi S; Costamagna D; Caponi A; Caponi C; Ciaccio B; Fiorentini G; Bolieraki A; Camassa M; Parma E; Scarcello E; Taddei P; Zappelli I
    Suppl Tumori; 2005; 4(3):S115. PubMed ID: 16437940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The Need for Accessible Data in Real Time.
    Balch GC; Bartlett DL
    Ann Surg Oncol; 2016 Jan; 23(1):9-11. PubMed ID: 26265367
    [No Abstract]   [Full Text] [Related]  

  • 48. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
    Helm CW
    Surg Oncol Clin N Am; 2012 Oct; 21(4):645-63. PubMed ID: 23021722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
    Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
    Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination.
    de Bree E; Romanos J; Relakis K; Tsiftsis DD
    Eur J Surg Oncol; 2005 Feb; 31(1):111-2. PubMed ID: 15642436
    [No Abstract]   [Full Text] [Related]  

  • 52. Analysis of operative morbidity in a single center initial experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Graziosi L; Mingrone E; Marino E; Cavazzoni E; Donini A
    Tumori; 2014; 100(1):15-20. PubMed ID: 24675485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.
    Esquivel J; Sticca R; Sugarbaker P; Levine E; Yan TD; Alexander R; Baratti D; Bartlett D; Barone R; Barrios P; Bieligk S; Bretcha-Boix P; Chang CK; Chu F; Chu Q; Daniel S; de Bree E; Deraco M; Dominguez-Parra L; Elias D; Flynn R; Foster J; Garofalo A; Gilly FN; Glehen O; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Goodman M; Gushchin V; Hanna N; Hartmann J; Harrison L; Hoefer R; Kane J; Kecmanovic D; Kelley S; Kuhn J; Lamont J; Lange J; Li B; Loggie B; Mahteme H; Mann G; Martin R; Misih RA; Moran B; Morris D; Onate-Ocana L; Petrelli N; Philippe G; Pingpank J; Pitroff A; Piso P; Quinones M; Riley L; Rutstein L; Saha S; Alrawi S; Sardi A; Schneebaum S; Shen P; Shibata D; Spellman J; Stojadinovic A; Stewart J; Torres-Melero J; Tuttle T; Verwaal V; Villar J; Wilkinson N; Younan R; Zeh H; Zoetmulder F; Sebbag G;
    Ann Surg Oncol; 2007 Jan; 14(1):128-33. PubMed ID: 17072675
    [No Abstract]   [Full Text] [Related]  

  • 54. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
    Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
    Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.
    Kusamura S; Baratti D; Deraco M
    Ann Surg; 2012 Feb; 255(2):348-56. PubMed ID: 22202584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal cancer?].
    Anthuber M; Straßmüller A
    Chirurg; 2021 Jun; 92(6):573. PubMed ID: 33885913
    [No Abstract]   [Full Text] [Related]  

  • 57. Current practices and future steps for hyperthermic intraperitoneal chemotherapy.
    Fields AC; Lu PW; Li GZ; Welten V; Jolissaint JS; Vierra BM; Saadat LV; Larson AC; Atkinson RB; Melnitchouk N
    Curr Probl Surg; 2020 Mar; 57(3):100727. PubMed ID: 32151327
    [No Abstract]   [Full Text] [Related]  

  • 58. Feasibility of delayed hyperthermic intraperitoneal chemotherapy in case of unforeseen complications.
    Mohr Z; Hirche C; Liebeskind U; Rau B; Hünerbein M
    Eur Surg Res; 2011; 47(1):19-25. PubMed ID: 21540615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.
    Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
    Ann Surg; 2011 Jul; 254(1):125-30. PubMed ID: 21502859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Fujimura T; Fushida S; Takegawa S; Kamata T; Katayama K; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    World J Surg; 1991; 15(4):530-5; discussion 535-6. PubMed ID: 1891941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.